BG50272A3 - Method for the preparation of (d)- alpha- ethyl- 2- oxo- 1- pyrolydinacetamide - Google Patents
Method for the preparation of (d)- alpha- ethyl- 2- oxo- 1- pyrolydinacetamideInfo
- Publication number
- BG50272A3 BG50272A3 BG070237A BG7023785A BG50272A3 BG 50272 A3 BG50272 A3 BG 50272A3 BG 070237 A BG070237 A BG 070237A BG 7023785 A BG7023785 A BG 7023785A BG 50272 A3 BG50272 A3 BG 50272A3
- Authority
- BG
- Bulgaria
- Prior art keywords
- oxo
- ethyl
- alpha
- denotes
- pyrolydinacetamide
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 abstract 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
- HPHUVLMMVZITSG-UHFFFAOYSA-N Etiracetam Chemical compound CCC(C(N)=O)N1CCCC1=O HPHUVLMMVZITSG-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 229910021529 ammonia Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 230000001343 mnemonic effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Detergent Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB848412358A GB8412358D0 (en) | 1984-05-15 | 1984-05-15 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG50272A3 true BG50272A3 (en) | 1992-06-15 |
Family
ID=10560975
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG070237A BG50272A3 (en) | 1984-05-15 | 1985-05-14 | Method for the preparation of (d)- alpha- ethyl- 2- oxo- 1- pyrolydinacetamide |
| BG094053A BG60030B2 (bg) | 1984-05-15 | 1985-05-14 | Метод за получаване на (d)-алфа-етил-2-оксо-1- пиролидинацетамид |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG094053A BG60030B2 (bg) | 1984-05-15 | 1985-05-14 | Метод за получаване на (d)-алфа-етил-2-оксо-1- пиролидинацетамид |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US4696942A (de) |
| EP (1) | EP0165919B1 (de) |
| JP (1) | JPS60255764A (de) |
| AT (1) | ATE45348T1 (de) |
| AU (1) | AU574175B2 (de) |
| BG (2) | BG50272A3 (de) |
| CA (1) | CA1237138A (de) |
| CY (1) | CY1568A (de) |
| DE (1) | DE3572168D1 (de) |
| DK (1) | DK163500C (de) |
| ES (2) | ES8703419A1 (de) |
| FI (1) | FI80674C (de) |
| GB (1) | GB8412358D0 (de) |
| GR (1) | GR851156B (de) |
| HK (1) | HK62692A (de) |
| IE (1) | IE58393B1 (de) |
| IL (1) | IL75180A (de) |
| NO (1) | NO164535C (de) |
| PL (2) | PL144345B1 (de) |
| PT (1) | PT80461B (de) |
| SG (1) | SG80190G (de) |
| SU (3) | SU1417799A3 (de) |
| ZA (1) | ZA853636B (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8412357D0 (en) * | 1984-05-15 | 1984-06-20 | Ucb Sa | Pharmaceutical composition |
| DE3420193A1 (de) * | 1984-05-30 | 1985-12-05 | Boehringer Ingelheim KG, 6507 Ingelheim | Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel |
| GB8827389D0 (en) * | 1988-11-23 | 1988-12-29 | Ucb Sa | Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
| US6124473A (en) * | 1998-05-08 | 2000-09-26 | Ucb, S.A. | Process for preparing (s)- and (R)-α-ethyl-2-oxo-1-pyrrolidineacetamide |
| GB0004297D0 (en) | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
| US7112612B2 (en) * | 2000-11-21 | 2006-09-26 | Ucb S.A. | N-alkylated GABA compounds, processes for their preparation and their use as medicaments |
| WO2002076451A1 (en) * | 2001-03-22 | 2002-10-03 | Ucb, S.A. | Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases |
| JP4334344B2 (ja) * | 2001-08-10 | 2009-09-30 | ユセベ ファルマ ソシエテ アノニム | オキソピロリジン化合物、当該化合物の調製、並びにレベチラセタム及び類似体の製造におけるその化合物の使用 |
| CA2546970C (en) | 2003-12-02 | 2011-04-26 | Ucb, S.A. | Imidazole derivatives, processes for preparing them and their uses |
| CA2488325C (en) * | 2004-11-22 | 2010-08-24 | Apotex Pharmachem Inc. | Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide |
| US8178533B2 (en) | 2005-06-01 | 2012-05-15 | Ucb Pharma, S.A. | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| EP2346500B1 (de) | 2008-10-16 | 2017-05-17 | The Johns Hopkins University | Verfahren und zusammensetzungen zur verbesserung der kognitiven funktion |
| TW201118103A (en) | 2009-10-23 | 2011-06-01 | Ucb Pharma Sa | 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives |
| EP2533645B1 (de) | 2010-02-09 | 2016-07-27 | The Johns Hopkins University | Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen |
| PL2699581T3 (pl) | 2011-04-18 | 2016-05-31 | Ucb Biopharma Sprl | Pochodne 2-okso-1-imidazolidynyloimidazotiadiazolu |
| CN102633675A (zh) * | 2012-04-10 | 2012-08-15 | 南京大学 | 一种dl-2-氨基丁酰胺制备方法 |
| US10154988B2 (en) | 2012-11-14 | 2018-12-18 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
| CA2904767C (en) | 2013-03-15 | 2022-06-21 | Agenebio, Inc. | Methods and compositions for improving cognitive function |
| US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
| PL3096790T3 (pl) | 2014-01-21 | 2020-01-31 | Janssen Pharmaceutica, N.V. | Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie |
| ME03518B (de) | 2014-01-21 | 2020-04-20 | Janssen Pharmaceutica Nv | Kombinationen mit positiven allosterischen modulatoren von metabotropem glutamatergen rezeptor vom subtyp 2 und deren verwendung |
| EA034167B8 (ru) | 2015-05-22 | 2021-04-27 | Эйджинбайо, Инк. | Фармацевтические композиции леветирацетама пролонгированного высвобождения |
| JP2022510363A (ja) | 2018-12-04 | 2022-01-26 | メティス ファーマシューティカルズ アクチェンゲゼルシャフト | (r)-2-(2-オキソピロリジン-1-イル)ブタンアミドと(s)-2-(2-オキソピロリジン-1-イル)ブタンアミドを非ラセミ比で含む相乗的組成物 |
| US11384050B1 (en) | 2021-02-03 | 2022-07-12 | Vitaworks Ip, Llc | Method for preparing levetiracetam and intermediates thereof |
| US12559456B2 (en) | 2021-02-03 | 2026-02-24 | Suzhou Brighthope Pharma Tech Co., Ltd | Method for preparing levetiracetam and intermediates thereof |
| US12590059B2 (en) | 2023-03-28 | 2026-03-31 | Suzhou Brighthope Pharmatech Co., Ltd | Process for the production of levetiracetam |
| US12528770B2 (en) | 2023-06-12 | 2026-01-20 | Suzhou Brighthope Pharmatech Co., Ltd. | Process for the production of levetiracetam and intermediates thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1309692A (en) * | 1970-02-13 | 1973-03-14 | Ucb Sa | N-substituted lactams |
| GB1583871A (en) * | 1976-10-19 | 1981-02-04 | Ucb Sa | Anti-aggregants |
| FR2418790A1 (fr) * | 1978-03-02 | 1979-09-28 | Philagro Sa | Nouveaux derives de pyrrolidinone-2 et compositions herbicides les contenant |
| AU579863B2 (en) * | 1984-05-16 | 1988-12-15 | Williams, David Andrew | A parking control apparatus |
-
1984
- 1984-05-15 GB GB848412358A patent/GB8412358D0/en active Pending
-
1985
- 1985-05-13 IL IL75180A patent/IL75180A/xx unknown
- 1985-05-13 GR GR851156A patent/GR851156B/el unknown
- 1985-05-13 FI FI851876A patent/FI80674C/fi not_active IP Right Cessation
- 1985-05-14 PL PL1985253373A patent/PL144345B1/pl unknown
- 1985-05-14 SU SU3892951A patent/SU1417799A3/ru active
- 1985-05-14 DE DE8585870068T patent/DE3572168D1/de not_active Expired
- 1985-05-14 AU AU42529/85A patent/AU574175B2/en not_active Ceased
- 1985-05-14 ZA ZA853636A patent/ZA853636B/xx unknown
- 1985-05-14 PT PT80461A patent/PT80461B/pt not_active IP Right Cessation
- 1985-05-14 BG BG070237A patent/BG50272A3/xx unknown
- 1985-05-14 ES ES543125A patent/ES8703419A1/es not_active Expired
- 1985-05-14 CA CA000481511A patent/CA1237138A/en not_active Expired
- 1985-05-14 US US06/733,791 patent/US4696942A/en not_active Expired - Lifetime
- 1985-05-14 DK DK212885A patent/DK163500C/da not_active IP Right Cessation
- 1985-05-14 JP JP60102530A patent/JPS60255764A/ja active Pending
- 1985-05-14 AT AT85870068T patent/ATE45348T1/de not_active IP Right Cessation
- 1985-05-14 IE IE119285A patent/IE58393B1/en not_active IP Right Cessation
- 1985-05-14 BG BG094053A patent/BG60030B2/bg unknown
- 1985-05-14 PL PL1985257386A patent/PL147387B1/pl unknown
- 1985-05-14 NO NO851934A patent/NO164535C/no not_active IP Right Cessation
- 1985-05-14 EP EP85870068A patent/EP0165919B1/de not_active Expired
- 1985-10-25 SU SU853968801A patent/SU1320207A1/ru active
-
1986
- 1986-01-29 ES ES551366A patent/ES8706114A1/es not_active Expired
- 1986-08-13 SU SU4027936A patent/SU1428194A3/ru active
-
1987
- 1987-03-12 US US07/025,278 patent/US4837224A/en not_active Expired - Lifetime
-
1990
- 1990-10-02 SG SG801/90A patent/SG80190G/en unknown
-
1991
- 1991-12-20 CY CY1568A patent/CY1568A/xx unknown
-
1992
- 1992-08-20 HK HK626/92A patent/HK62692A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK496089A (da) | Biologisk aktive phenylalkansyreforbindelser og fremgangsmaade til fremstilling deraf | |
| BG60262B1 (bg) | Метод за получаване на заместени двупръстенни съединения | |
| ES8703860A1 (es) | Un procedimiento para preparar derivados de aminoalquilfenaxi. | |
| ES2000185A6 (es) | Procedimiento para preparar derivados de acidos piridoncaboxilicos | |
| BG50939A3 (bg) | Метод за получаване на пиридазинонови производни | |
| PT80461A (fr) | Procede de preparation du (r)-alfa-ethyl-2-oxo-1-pyrrolidine-acetamide | |
| ES2000910A6 (es) | Procedimiento para preparar piridina-2,3-dicarboxilatos sustituidos y disustituidos | |
| DE3370585D1 (en) | Use of aminophenylacetic acid derivatives for the manufacture of an immunomodulating medical preparation | |
| ES2043830T3 (es) | Un metodo para preparar un compuesto de bis-(metilenodioxi)bifenilo. | |
| FR2355796A1 (fr) | Procede de preparation de fluorures d'acides perfluoro-alcoxy-propioniques | |
| ES8704445A1 (es) | Procedimiento de preparar derivados aminicos | |
| ES8306371A1 (es) | "un procedimiento para la preparacion de sales de s-adenosilmetionina". | |
| DE3477488D1 (en) | Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives | |
| ES468501A1 (es) | Un procedimiento para la preparacion de derivados de imida- zodiacepina. | |
| IL63648A (en) | Azolylalkanoic acid(or nitrile)derivatives,their preparation and their use as fungicides | |
| ES8801298A3 (es) | Un procedimiento para la preparacion de un complejo de platino | |
| DK422183A (da) | Fremgangsmaade til fremstilling af 5-halogenvinyl-2'-deoxyuridinderivater | |
| FR2443460A1 (fr) | Derives mercaptoacyles d'acides 4,5-dihydro-1h-pyrrole-2-carboxyliques et d'acides 1,4,5,6-tetrahydropyridine-2-carboxyliques, utiles comme agents hypotenseurs | |
| IL73042A (en) | Oximes of beta-(1-azolylmethyl)-beta-hydroxyaryl-acetaldehydes and aralkylketones,their preparation and their use as fungicides | |
| ES8304920A1 (es) | Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos. | |
| DK161648C (da) | I 3-, 7- og 9-stillingen substituerede 2,4,6,8-tetraoxo-3,7-diazabicyclooe3,3,1aanonan-forbindelser og laegemiddel indeholdende disse | |
| FR2385723A1 (fr) | Procede d'epimerisation d'une thiazolidine-azetidinone | |
| GB1455169A (en) | Amidic derivatives of nicotinic acid | |
| EP0024866A3 (de) | Mildiomycin-Analoge, Verfahren zu ihrer Herstellung und pestizide Mittel daraus | |
| EP0301466A3 (en) | Uricosuric composition |